CLINICAL IMPLICATIONS OF DRUG-INTERACTIONS WITH THE CYTOCHROME-P-450 ENZYME-SYSTEM ASSOCIATED WITH OMEPRAZOLE

被引:40
作者
HUMPHRIES, TJ [1 ]
机构
[1] MERCK SHARP & DOHME LTD,W POINT,PA 19486
关键词
CYTOCHROME P-450; DRUG METABOLISM; OMEPRAZOLE; CIMETIDINE; DRUG INTERACTIONS;
D O I
10.1007/BF01296606
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Interactions with the hepatic cytochrome P-450 microsomal enzyme system, as evidenced by statistically significant changes in pharmacokinetic parameters, have been described with some H2-receptor antagonists. Omeprazole is the first of a new class of antisecretory agents inhibiting gastric secretion by blocking hydrogen potassium ATPase. Omeprazole contains a benzimidazole moiety and thus has the potential to interact with the cytochrome P-450 enzyme group. In vitro, in vivo and human clinical studies have assessed whether such an interaction occurs, and the potential clinical consequences, in patients receiving omeprazole therapy. In vitro studies have demonstrated that omeprazole influences O-deethylation and N-demethylation in liver microsomes and the clearance and elimination half-life of antipyrine in isolated perfused liver preparations. Overall, the studies reviewed suggest that omeprazole has a differential affinity toward specific cytochrome P-450 isozymes. In vivo animal studies have demonstrated that omeprazole prolongs pentobarbital sleep times and half-life and decreases [C-14]-aminopyrine elimination. Human clinical studies have not demonstrated the "all or none" effect of omeprazole on cytochrome P-450-mediated drug interactions, as is seen with cimetidine. These studies confirm in vitro findings that omeprazole is a differential inhibitor of drug metabolism: interactions have been demonstrated with the model drugs aminopyrine and antipyrine, and the therapeutic drugs diazepam, phenytoin, and warfarin but not with theophylline or propranolol. Although caution should be exercised when initiating omeprazole therapy in patients taking concomitant diazepam, warfarin, and phenytoin, clinically significant drug interactions appear unlikely.
引用
收藏
页码:1665 / 1669
页数:5
相关论文
共 50 条
[31]   Bioelectrochemical Systems as Technologies for Studying Drug Interactions Related to Cytochrome P450 [J].
Shumyantseva, Victoria V. ;
Makhova, Anna A. ;
Shikh, Evgenia V. ;
Bulko, Tatiana V. ;
Kuzikov, Alexey V. ;
Masamrekh, Rami A. ;
Shkel, Tatyana ;
Usanov, Sergey ;
Gilep, Andrei ;
Archakov, Alexander I. .
BIONANOSCIENCE, 2019, 9 (01) :79-86
[32]   Drug interactions in palliative care - it's more than cytochrome P450 [J].
Gaertner, Jan ;
Ruberg, Klaus ;
Schlesiger, Grit ;
Frechen, Sebastian ;
Voltz, Raymond .
PALLIATIVE MEDICINE, 2012, 26 (06) :813-825
[33]   Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450 [J].
Gubbins, Paul O. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (11) :1411-1429
[34]   African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development [J].
Rajman, Iris ;
Knapp, Laura ;
Morgan, Thomas ;
Masimirembwa, Collen .
EBIOMEDICINE, 2017, 17 :67-74
[35]   Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug–drug interactions: a PharmacoVigilance study in France [J].
Anne Charlotte Danton ;
François Montastruc ;
Agnès Sommet ;
Geneviève Durrieu ;
Haleh Bagheri ;
Emmanuelle Bondon-Guitton ;
Maryse Lapeyre-Mestre ;
Jean-Louis Montastruc .
European Journal of Clinical Pharmacology, 2013, 69 :885-888
[36]   THE MAINTENANCE OF CYTOCHROME-P-450 IN RAT HEPATOCYTE CULTURE - SOME APPLICATIONS OF LIVER-CELL CULTURES TO THE STUDY OF DRUG-METABOLISM, TOXICITY AND THE INDUCTION OF THE P-450 SYSTEM [J].
PAINE, AJ .
CHEMICO-BIOLOGICAL INTERACTIONS, 1990, 74 (1-2) :1-31
[37]   Interactions of omeprazole-based analogues with cytochrome P450 2C19: a computational study [J].
Li, Junhao ;
Du, Hanwen ;
Wu, Zengrui ;
Su, Haixia ;
Liu, Guixia ;
Tang, Yun ;
Li, Weihua .
MOLECULAR BIOSYSTEMS, 2016, 12 (06) :1913-1921
[38]   Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism A retrospective study [J].
Naujokaitis, Domas ;
Asmoniene, Virginija ;
Kadusevicius, Edmundas .
MEDICINE, 2021, 100 (11) :E24545
[39]   Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications [J].
Zhang, Yan-Yan ;
Yang, Ling .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (06) :621-629
[40]   In vitro drug-drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes [J].
Chen, Nancy ;
Cui, Donghui ;
Wang, Qing ;
Wen, Zhiming ;
Finkelman, Richard D. ;
Welty, Devin .
XENOBIOTICA, 2018, 48 (06) :637-646